Xiaoxian Dong

Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth

Ningning Liu, Xiaofen Li, Hongbiao Huang et al. · Oncotarget · 2014 · 169 citations · Full text

Physiological levels of ATP negatively regulate proteasome function

Hongbiao Huang, Xiaoyan Zhang, Shujue Li et al. · Cell Research · 2010 · 141 citations · Full text

Energy Metabolism, Molecular Physiology, Biochemistry +8

Gambogic Acid Is a Tissue-Specific Proteasome Inhibitor In Vitro and In Vivo

Xiaofen Li, Shouting Liu, Hongbiao Huang et al. · Cell Reports · 2012 · 85 citations · Full text

Proteasome, Glioma, Tumor Biology +20

Treatment with hydrogen molecules prevents RANKL-induced osteoclast differentiation associated with inhibition of ROS formation and inactivation of MAPK, AKT and NF-kappa B pathways in murine RAW264.7 cells

Dong-Zhu Li, Qing-Xiang Zhang, Xiaoxian Dong et al. · Journal of Bone and Mineral Metabolism · 2013 · 55 citations

Hydrogen Molecules, Sclerostin, Developmental Biology +9

A microRNA-mediated decrease in eukaryotic initiation factor 2α promotes cell survival during PS-341 treatment

Lili Jiang, Dan Zang, Songgang Yi et al. · Scientific Reports · 2016 · 26 citations · Full text